Thus, our analysis suggests the hypothesis that DVL3 amplifications, coupled with decrease in CXXC4 expression, could drive ovarian cancer progression through enhanced activation of the Wnt signaling pathway. Here, DVL3 is linked to ovarian carcinoma.